Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $4.48 | Change: +$0.24 | %Change: +5.66%
Volume: 145,175 | Day High/Low: 4.50/4.24 | 52 Week High/Low: 5.73/1.58
View modes: 
0 stars

RE:RE:US Listing for Nuvo Research, NRI on the Nasdaq?...How Nice!

This is all part of the Nuvo end game. Pay back the shareholders... the new ones and the ones that lost so much that are still here.  The stock is steadily climbing but has a long way to go. I...read more
5 stars

RE:US Listing for Nuvo Research, NRI on the Nasdaq?...How Nice!

In an RTO by a US acquirer, all conditions of the income tax act would be met and the forward tax loss pools would be fully useable in their totality. In other words, there would be a double tax...read more
5 stars

US Listing for Nuvo Research, NRI on the Nasdaq?...How Nice!

With the share price struggles obviously behind us, could we finally see the US listing for Nuvo Research. Just the kind of investor exposure NRI shareholders would enjoy, especially with all the...read more
0 stars

re:week-end speculation

john,i agree totally with your speculation a takeover before Christmas,yes pick more shares before 5  rate and reply
5 stars

Weekend Speculation

As indicated in Nuvo's latest corporate presentation an outright sale of the U.S, Pennsaid and P2 franchise is on the table. Most would agree that the valuation for a sale would be materially higher...read more
4 stars

RE:RE:1.5% of the company's shares traded hands today.

i know nothing except for the fact that my hard earned money has been unethically wiped from me by these clowns running this company.  i care not about legalities...i follow a higher principle called...read more
0 stars

RE:1.5% of the company's shares traded hands today.

Hey Phil,you come across to me as someone who is in the know. Maybe you can you tell me about the ticker DNDN and how many shrares it traded hands today and WHY ?for I ,not being a very bright...read more
3.5 stars

1.5% of the company's shares traded hands today.

something is up for sure.  i just hope the money any shareholders make from this move can be parlayed into suing the clowns running this company for unjust enrichment if at all justified and possible....read more
5 stars

More questions - no answers for retail investors

Question - So what exactly is the difference between relicencing and selling the rights to U.S. Pennsaid? We had a licensing deal with MNK where Nuvo sold Pennsaid at a wholesale price to MNK which...read more
3.5 stars

RE:RE:RE:RE:RE:RE:RE:Something's brewing

Anyone who is so naive as to think that a microcap pharma can develop new drugs from scratch and bring it to market without severe and repeated dilutions requiring several share consolidations...read more
5 stars

Investor Presentation Revised

See the Nuvo website. Also, the Rock07 is right about the risks of small Pharma.  Consider that Nuvo has a current lifetime deficit of $236M, if the company was sold for less than $24/share, this...read more
2 stars

RE:RE:RE:RE:RE:RE:Something's brewing

Anyone who is so naive as to think that a microcap pharma can develop new drugs from scratch and bring it to market without severe and repeated dilutions requiring several share consolidations...read more
5 stars

RE:RE:RE:RE:RE:Something's brewing

I chucked when I read your post last night but too tired to respond. I was out yesterday and wanted to think a little more about what is happening. To your point about valuation this management group...read more
3 stars

RTO for Tax benefits

Recently Paladin was taken out by Endo and HQ moved to Canada where the tax rate is only 60% of that in the US. QLT is a more recent example. NRI stands out like a sore thumb as another possible RTO...read more
3 stars

RE:RE:Time to get the wife working. Need2 get cash in.

Cumulative sales would probably exceed $250 million when geographic expansion is considered. Cant imagine that the franchise would be sold for anything less than $75 million. Given the fact that WF10...read more
3 stars

same old same old

nothing seems to change with Nuvo. news is ALWAYS underwhelming, including the latest "win" with a meager $10 million settlement from Mallinkrap. just on a cash basis alone, the $10m is worth $1 per...read more
4 stars

RE:Time to get the wife working. Need2 get cash in.

Need2, Great to have you and your humour back. as.we need2 have a good dose of humuor with this company... Updated presentation today and I noticed the following statement which is something new for...read more
5 stars

RE:RE:RE:RE:Something's brewing

Consultant ,I hope you did not take offence to one of my previous posts as that was just me trying to be funny. I for one have nothing but the utmost respect for you and your insight when it comes to...read more
3 stars

Time to get the wife working. Need2 get cash in.

My old lady needs2 get out in the work force and pull her wait. She will be working the drive thru. If your knees get sore I know something that will do the trick........try a chair. Love you hun...read more
4 stars

Pennsaid Future

A few days ago I shared my thoughts about the future of the Nuvo Pain Franchise. Take a look at the latest Investor Bulletin: for the first time (I think) reference is made to Re-licensing or SALE of...read more